A new vaccination programme aimed at protecting new born babies and older adults against the Respiratory Syncytial Virus (RSV) and its complications has been approved in Northern Ireland.

Covid-19 levels in the United States are high and rising, flu season is approaching quickly, and RSV cases are already starting to tick up. Forecasts from the US Centers for Disease Control and ...

RSV, or respiratory syncytial virus, is a common cause of coughs and colds which can also lead to severe lung infections like pneumonia and infant bronchiolitis – conditions which are highly ...

The Centers for Disease Control and Prevention recommends adults 75 and older and those 60 and older at risk of respiratory diseases get a shot to protect against respiratory syncytial virus ...

The vaccine for RSV is being expanded to pregnant women and older people, with the NHS beginning rollout this week. The NHS says the vaccines could prevent thousands of hospital admissions for ...

Jane Tuckerman has previously received funding from GlaxoSmithKline (investigator-led research). Funding has been directed to her research institution. There are no conflicts relevant to this article.

CORRECTION: An earlier version of this story misstated the number of RSV vaccines approved for older adults. There are three vaccines. The pools are closing, the kids are back in school and ...

As a paediatrician in training, Jacqueline Miller was struck by how, every winter, she saw a steep rise in the numbers of patients with two conditions: respiratory syncytial virus (RSV ...

This year in addition to flu and Covid-19 some people will be given RSV jabs as the NHS sets out plans for protection ahead of winter. The vaccines provide essential protection to help stop people ...